Similarly, It has been reported that the lncRNA MALAT1 can lead to H3K27me3 modification by interacting with the enhancer of zeste homolog 2 (EZH2), inducing its target genes in DLBCL and other malignancies [126]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.